And 2 Abstracts at EHA.
Commercial company in 2023 - there certainly is a light at the end of this long, long, long (choose your own # of long!) tunnel.
However the company is now projecting a confidence in Approval that is undeniable and I too am confident that, barring force majeur, approval is a given.
Will the EHA unposted data change the context from layup to slam dunk?
75% Enrollment in MDS Phase III
Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
Re: 75% Enrollment in MDS Phase III
I doubt we will get any meaningful good news from the coming EHA based on scarlet saying the 2 abstracts are based on the P2 data.
Extensions to survival ofc is amazing, just not currently for the share price.
Late breaking abstracts vaguely possible, but as they seem to be playing the long game so I doubt it.
Extensions to survival ofc is amazing, just not currently for the share price.
Late breaking abstracts vaguely possible, but as they seem to be playing the long game so I doubt it.